Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: A prospective study of 35 patients

Arthritis Care and Research

Volumn 55, Issue 1, 2006, Pages 131-137

  Blockmans, Daniël ^a   De Ceuninck, Liesbet ^a   Vanderschueren, Steven ^a   Knockaert, Daniël ^a   Mortelmans, Luc ^a   Bobbaers, Herman ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Giant cell arteritis; PET; Polymyalgia rheumatica; Positron emission tomography; Vasculitis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHYLPREDNISOLONE; STEROID; ANTIINFLAMMATORY AGENT; DIAGNOSTIC AGENT;

AGED; AORTA; ARTICLE; CLINICAL ARTICLE; DISEASE MARKER; DRUG UPTAKE; FEMALE; FEMORAL ARTERY; GIANT CELL ARTERITIS; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; MALE; MAMMARY ARTERY; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY; RELAPSE; RHEUMATIC POLYMYALGIA; SCORING SYSTEM; SHOULDER; STEROID THERAPY; SUBCLAVIAN ARTERY; SYMPTOMATOLOGY; SYNOVITIS; CLINICAL TRIAL; FOLLOW UP; METHODOLOGY; PREDICTION AND FORECASTING; RECURRENT DISEASE; RISK; SCINTISCANNING; TEMPORAL ARTERITIS; TREATMENT OUTCOME;

AGED; ANTI-INFLAMMATORY AGENTS; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MALE; METHYLPREDNISOLONE; POLYMYALGIA RHEUMATICA; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECURRENCE; RISK; SHOULDER JOINT; TEMPORAL ARTERITIS; TREATMENT OUTCOME;

EID: 32544453865     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.21699     Document Type: Article

References (12)

1. Blockmans D, Maes A, Stroobants S, Nuyts J, Bormans G, Knockaert D, et al. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford) 1999;38:444-7.
2. Blockmans D, Stroobants S, Maes A, Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 2000;108:246-9.
3. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982;97:672-80.
4. Turlakow A, Yeung HW, Pui J, Macapinlac H, Liebovitz E, Rusch V, et al. Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis. Arch Intern Med 2001;161:1003-7.
5. Brodmann M, Lipp RW, Passath A, Seinost G, Pabst E, Pilger E. The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford) 2004;43:241-2.
6. Scheel AK, Meller J, Vosshenrich R, Kohlhoff E, Siefker U, Muller GA, et al. Diagnosis and follow up of aortitis in the elderly. Ann Rheum Dis 2004;63:1507-10.
7. Cantini F, Niccoli L, Storri L, Nannini C, Olivieri I, Padula A, et al. Are polymyalgia rheumatica and giant cell arteritis the same disease? Semin Arthritis Rheum 2004;33:294-301.
8. Rojo-Leyva F, Ratliff NB, Cosgrove DM III, Hoffman GS. Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum 2000;43:901-7.
9. Brack A, Martinez-Taboada V, Stanson A, Goronzy JJ, Weyand CM. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999;42:311-7.
10. Brack A, Rittner HL, Younge BR, Kaltschmidt C, Weyand CM, Goronzy JJ. Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras. J Clin Invest 1997;99:2842-50.
11. Proven A, Gabriel SE, Orces C, O'Fallon WM, Hunder GG. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum 2003;49:703-8.
12. Salavarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002;347:261-71.